Glenmark Pharmaceuticals Share Price NSE Live

Q: What is the current share price of Glenmark Pharmaceuticals?

The current share price of Glenmark Pharmaceuticals is ₹2271.10.

Q: What sector does Glenmark Pharmaceuticals operate in?

Glenmark Pharmaceuticals operates in the Healthcare sector. Understanding the sector helps investors grasp market trends, which directly influence share prices.

Q: What is the P/E ratio of Glenmark Pharmaceuticals?

The current P/E ratio of Glenmark Pharmaceuticals is ₹26.99. P/E ratio measures Glenmark Pharmaceuticals share price relative to its earnings per share, offering insight into the company's valuation.

Q: What is the P/B ratio of Glenmark Pharmaceuticals?

The current P/B ratio of Glenmark Pharmaceuticals is ₹1.77. The Price-to-Book (P/B) ratio compares Glenmark Pharmaceuticals share price to its book value per share, indicating how much investors are willing to pay for each unit of net assets.

Q: What is the 52w high and low of Glenmark Pharmaceuticals?

The 52-week high of Glenmark Pharmaceuticals is ₹2474.00, and the 52-week low is ₹1408.10. These 52-week high and low values help investors assess the stock's price volatility and trading opportunities.

Home

Stocks

Glenmark Pharmaceuticals

NSE: GLENMARK

Healthcare

₹2271.10113.804.77%(1D)

Option Chain

●Closed

29 May 2026, 08:44 pm

Terminal

Option Chain

Performance Stats for Glenmark Pharmaceuticals

Day Range

Low: ₹2257.80

High: ₹2400.70

₹2271.10

52 Week Range

Low: ₹1408.10

High: ₹2474.00

₹2271.10

Open Price

2400.00

Previous Close

2384.90

Volume

1066954.00

Open Price

2400.00

Previous Close

2384.90

Volume

1066954.00

Fundamentals of Glenmark Pharmaceuticals

ROCE

8.94%

EPS

₹52.57

Dividend Yield

0.16%

P/E Ratio

26.99

P/B Ratio

1.77

Debt to Equity

0.03

Current Ratio

1.25

Sales Growth

-16.79%

Profit Growth

-99.66%

EBIT Growth

-98.85%

Financials of Glenmark Pharmaceuticals

All values in Rs. Cr

QTR

Share Holding Pattern of Glenmark Pharmaceuticals

Promoter

46.65%

Foreign institutions

20.34%

Mutual Funds

16.80%

Other

16.20%

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development,...

Stocks	CMP
Alembic Pharma	₹735.85 2.43%
Aurobindo Pharma	₹1427.8 0.56%
Cipla	₹1400 1.28%
Ipca Laboratories	₹1525.3 3%

Frequently Asked Questions

Q1. What is the current share price of Glenmark Pharmaceuticals?

Q2. What sector does Glenmark Pharmaceuticals operate in?

Q3. What is the P/E ratio of Glenmark Pharmaceuticals?

Q4. What is the P/B ratio of Glenmark Pharmaceuticals?

Q5. What is the 52w high and low of Glenmark Pharmaceuticals?

Glenmark Pharmaceuticals

Performance Stats for Glenmark Pharmaceuticals

Fundamentals of Glenmark Pharmaceuticals

Financials of Glenmark Pharmaceuticals

Share Holding Pattern of Glenmark Pharmaceuticals

About Glenmark Pharmaceuticals

Similar Sector Stocks

Most Viewed Stocks

Open Interest (OI)

Glenmark Pharmaceuticals Options

Events Related to Glenmark Pharmaceuticals

News About Glenmark Pharmaceuticals

Frequently Asked Questions